Buprenorphine/Samidorphan Helpful in Refractory Depression

TUESDAY, Nov. 6, 2018 -- An adjunctive buprenorphine/samidorphan (BUP/SAM) combination seems beneficial for patients with major depressive disorder (MDD) with inadequate response to antidepressant therapy (ADT), according to a study published online...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news